Peptilogics
The Chief Financial Officer at Peptilogics will lead all financial, accounting, treasury, and investor‑relations activities, shaping the company’s capitalization strategy and scaling financial operations as it moves from late‑stage development toward commercial growth. The role involves driving fundraising, overseeing financial planning and reporting, managing transactions such as M&A and licensing, and collaborating closely with the CEO, senior leadership, and Board.
Peptilogics is a biotechnology company focused on peptide therapeutics, using custom engineering to design and develop next‑generation peptide drugs. They provide tailored peptide design, synthesis and optimization services to support drug discovery and preclinical development for research groups and industry partners. Branded “Custom Engineered with Intention,” Peptilogics positions itself to accelerate translation of peptide technologies into therapeutic candidates and collaborations.
Peptilogics Raises $78 Million to Advance Zaloganan Into Pivotal Trial
Oct 16, 2025
Peptilogics raises millions to fund pivotal trial for prosthetic joint infection treatment
Oct 16, 2025
South Side biotech company raises $78 million for new drug to kill prosthetic joint infections
Oct 16, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Peptilogics.
Peptilogics didn’t post a salary, so this is our estimate from similar listings.
9% above the average for this role
Peptilogics: $78 Million Raised For Advancing Zaloganan Toward Pivotal Trial For Prosthetic Joint Infections
Oct 16, 2025